Coupled proliferation and apoptosis maintain the rapid turnover of microglia in the adult brain
Compounded semaglutide and tirzepatide maintain the same active pharmaceutical ingredients as their branded counterparts but are produced through licensed 503A pharmacies
Pharma execs detail strategies for govt pricing deals, countering vaccine skepticism, and driving D2C sales at FTs US Pharma and Biotech Summit
What the new mechanism is: GLP-1 : appetite regulation, improved glucose control GIP : incretin effects that may augment metabolic benefits Glucagon receptor activity : potentially influences energy expenditure and fat metabolism (while requiring careful balancing of tolerability and metabolic effects) What results look like (so far): Phase 2 (48 weeks) published in NEJM showed substantial mean weight reductions (with higher doses showing very large effects)
all of them suggest the field believes triple-mechanism peptides are where therapeutic ceilings stop being theoretical and start being practical
The most frequently reported side effects include headache, nausea, vomiting, diarrhea, fatigue and injection-site reactions [5]
